Skip to content
Pricing
Sample Reports
Show submenu for Sample Reports
Company Report
Drug Report
Disease Report
Solutions
Show submenu for Solutions
Investors
Portfolio Managers
Research
Publisher Content
Resources
Show submenu for Resources
Case Studies
Demo Videos
Market Intelligence Datasets
Drug Index
FAQs
API Documentation
Company
Show submenu for Company
News & Updates
Leadership
CDD Vault
Contact Us
Login
Pricing
Sample Reports
Show submenu for Sample Reports
Company Report
Drug Report
Disease Report
Solutions
Show submenu for Solutions
Investors
Portfolio Managers
Research
Publisher Content
Resources
Show submenu for Resources
Case Studies
Demo Videos
Market Intelligence Datasets
Drug Index
FAQs
API Documentation
Company
Show submenu for Company
News & Updates
Leadership
CDD Vault
Contact Us
Login
Benzimidazole
Benznidazole (benzimidazole) is a small molecule pharmaceutical. Benzimidazole was first approved as Benznidazole on 2017-08-29. It is known to target fMet-Leu-Phe receptor.
Trade Name
Benznidazole
Common Name
Benzimidazole
Indication
Drug Class